Advertisement
Screener

IQVIA HOLDINGS INC. (IQV) OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax

IQVIA HOLDINGS INC. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax

IQVIA HOLDINGS INC. (IQV) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax of $12.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.

Discontinued › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax · last filed 2016-11-03

  • IQVIA HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2016-09-30 was $12.00K.
  • IQVIA HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2016-06-30 was $49.00K, a 444.44% increase year-over-year.
  • IQVIA HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2016-03-31 was -$56.00K.
  • IQVIA HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2015-12-31 was -$33.00K.
  • IQVIA HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2015 was -$168.00K.
  • IQVIA HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2014 was -$376.00K, a 118.65% decline from fiscal 2013.
  • IQVIA HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2013 was $2.02M, a 681.40% increase from fiscal 2012.
  • IQVIA HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2012 was $258.00K.
Period endOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 6 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 9 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month
2016-09-30$12.00K
10-Q · filed 2016-11-03
$61.00K
derived: sum of 2 quarters · filed 2016-11-03
$5.00K
10-Q · filed 2016-11-03
-$28.00K
derived: sum of 4 quarters · filed 2016-11-03
2016-06-30$49.00K
10-Q · filed 2016-07-27
-$7.00K
10-Q · filed 2016-07-27
-$40.00K
derived: sum of 3 quarters · filed 2016-07-27
-$80.00K
derived: sum of 4 quarters · filed 2016-11-03
2016-03-31-$56.00K
10-Q · filed 2016-05-03
-$89.00K
derived: sum of 2 quarters · filed 2016-05-03
-$129.00K
derived: sum of 3 quarters · filed 2016-11-03
-$120.00K
derived: sum of 4 quarters · filed 2016-11-03
2015-12-31-$33.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11
-$73.00K
derived: sum of 2 quarters · filed 2016-11-03
-$64.00K
derived: sum of 3 quarters · filed 2016-11-03
-$168.00K
10-K · filed 2016-02-11
2015-09-30-$40.00K
10-Q · filed 2016-11-03
-$31.00K
derived: sum of 2 quarters · filed 2016-11-03
-$135.00K
10-Q · filed 2016-11-03
-$217.00K
derived: sum of 4 quarters · filed 2016-11-03
2015-06-30$9.00K
10-Q · filed 2016-07-27
-$95.00K
10-Q · filed 2016-07-27
-$177.00K
derived: sum of 3 quarters · filed 2016-07-27
-$181.00K
derived: sum of 4 quarters · filed 2016-07-27
2015-03-31-$104.00K
10-Q · filed 2016-05-03
-$186.00K
derived: sum of 2 quarters · filed 2016-05-03
-$190.00K
derived: sum of 3 quarters · filed 2016-05-03
-$1.69M
derived: sum of 4 quarters · filed 2016-05-03
2014-12-31-$82.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11
-$86.00K
derived: sum of 2 quarters · filed 2016-02-11
-$1.58M
derived: sum of 3 quarters · filed 2016-02-11
-$376.00K
10-K · filed 2016-02-11
2014-09-30-$4.00K
10-Q · filed 2015-10-28
-$1.50M
derived: sum of 2 quarters · filed 2015-10-28
-$294.00K
10-Q · filed 2015-10-28
$875.00K
derived: sum of 4 quarters · filed 2016-02-11
2014-06-30-$1.50M
10-Q · filed 2015-07-29
-$290.00K
10-Q · filed 2015-07-29
$879.00K
derived: sum of 3 quarters · filed 2016-02-11
$1.70M
derived: sum of 4 quarters · filed 2016-02-11
2014-03-31$1.21M
10-Q · filed 2015-04-29
$2.38M
derived: sum of 2 quarters · filed 2016-02-11
$3.20M
derived: sum of 3 quarters · filed 2016-02-11
$3.20M
derived: sum of 4 quarters · filed 2016-02-11
2013-12-31$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11
$1.99M
derived: sum of 2 quarters · filed 2016-02-11
$1.99M
derived: sum of 3 quarters · filed 2016-02-11
$2.02M
10-K · filed 2016-02-11
2013-09-30$821.00K
10-Q · filed 2014-10-30
$821.00K
derived: sum of 2 quarters · filed 2014-10-30
$847.00K
10-Q · filed 2014-10-30
$780.00K
derived: sum of 4 quarters · filed 2015-02-12
2013-06-30$0.00
10-Q · filed 2014-07-31
$26.00K
10-Q · filed 2014-07-31
-$41.00K
derived: sum of 3 quarters · filed 2015-02-12
$328.00K
derived: sum of 4 quarters · filed 2015-02-12
2013-03-31$26.00K
10-Q · filed 2014-05-01
-$41.00K
derived: sum of 2 quarters · filed 2015-02-12
$328.00K
derived: sum of 3 quarters · filed 2015-02-12
$277.00K
derived: sum of 4 quarters · filed 2015-02-12
2012-12-31-$67.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12
$302.00K
derived: sum of 2 quarters · filed 2015-02-12
$251.00K
derived: sum of 3 quarters · filed 2015-02-12
$258.00K
10-K · filed 2015-02-12
2012-09-30$369.00K
10-Q · filed 2013-10-31
$318.00K
derived: sum of 2 quarters · filed 2013-10-31
$325.00K
10-Q · filed 2013-10-31
2012-06-30-$51.00K
10-Q · filed 2013-08-01
-$44.00K
10-Q · filed 2013-08-01
2012-03-31$7.00K
10-Q · filed 2013-05-14
2011-12-31-$37.00K
10-K · filed 2014-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
INCYTE CORP (INCY)United States$24.855B13.14
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B